Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorShengjing Hospital

About this trial

The goal of this study is to investigate the value of noninvasive evaluation of multimodal magnetic resonance imaging in diagnosis and treatment of diabetic kidney disease (DKD). We aim to explore the feasibility of multimodal magnetic resonance imaging in the staging diagnosis of DKD, and establish a non-invasive method for evaluating the progression of DKD disease by combining imaging and biochemical indicators. Multimodal magnetic resonance examinations will be performed on diabetic patients with different stages as well as regular follow-up during treatment, in order to investigate the relationship between imaging findings and pathophysiological changes of the kidneys.

Eligibility criteria

Qualifiers

Clinically diagnosed diabetic kidney disease (DKD)

Age 18-80 years

Disqualifiers

Malignant tumor, active infection, or life expectancy <1 year

Pregnancy or lactation

MRE contraindications (metal implants, claustrophobia, severe arrhythmia) or poor image quality

eGFR <15 mL/min/1.73m² or receiving renal replacement therapy

Trial design

Treatments tested in this trial

  • Magnetic Resonance Imaging

Treatment groups

150 Participants
are divided into 2 treatment groups

Sponsors and collaborators